Business Description
Qurient Co Ltd
ISIN : KR7115180002
Compare
Compare
Traded in other countries / regions
115180.Korea IPO Date
2016-02-29Description
Qurient Co Ltd is a South Korea based biotech company. It is engaged in network research & development business model, integrating research and drug development programs with a new mechanism. Its pipeline products include Q301 for the treatment of atopic dermatitis; Q203 treats MDR/XDR/TDR TB, and Q701 is a drug-resistant cancer immuno-oncology.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 40.84 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 13.63 | |||||
| Beneish M-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 15.6 | |||||
| 3-Year EPS without NRI Growth Rate | -4.5 | |||||
| 3-Year FCF Growth Rate | 14.7 | |||||
| 3-Year Book Growth Rate | -25.4 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.2 | |||||
| 9-Day RSI | 64.93 | |||||
| 14-Day RSI | 61.49 | |||||
| 6-1 Month Momentum % | -4.22 | |||||
| 12-1 Month Momentum % | 29.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.08 | |||||
| Quick Ratio | 13.03 | |||||
| Cash Ratio | 12.67 | |||||
| Days Inventory | 8.66 | |||||
| Days Sales Outstanding | 38.23 | |||||
| Days Payable | 2.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -25.9 | |||||
| Shareholder Yield % | -9.12 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.46 | |||||
| Operating Margin % | -265.73 | |||||
| Net Margin % | -243.22 | |||||
| FCF Margin % | -232.71 | |||||
| ROE % | -61.4 | |||||
| ROA % | -51.6 | |||||
| ROIC % | -257.49 | |||||
| ROC (Joel Greenblatt) % | -3699.78 | |||||
| ROCE % | -57.96 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 14 | |||||
| PB Ratio | 3.06 | |||||
| Price-to-Tangible-Book | 3.23 | |||||
| EV-to-EBIT | -5.08 | |||||
| EV-to-EBITDA | -5.27 | |||||
| EV-to-Revenue | 12.9 | |||||
| EV-to-FCF | -4.98 | |||||
| Price-to-Net-Current-Asset-Value | 3.73 | |||||
| Price-to-Net-Cash | 3.78 | |||||
| Earnings Yield (Greenblatt) % | -19.71 | |||||
| FCF Yield % | -13.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Qurient Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 8,752.747 | ||
| EPS (TTM) (â‚©) | -820.351 | ||
| Beta | 0.57 | ||
| Volatility % | 91.91 | ||
| 14-Day RSI | 61.49 | ||
| 14-Day ATR (â‚©) | 281.957426 | ||
| 20-Day SMA (â‚©) | 4498.25 | ||
| 12-1 Month Momentum % | 29.56 | ||
| 52-Week Range (â‚©) | 2038.471332 - 6500 | ||
| Shares Outstanding (Mil) | 29.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Qurient Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Qurient Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Qurient Co Ltd Frequently Asked Questions
What is Qurient Co Ltd(XKRX:115180)'s stock price today?
The current price of XKRX:115180 is â‚©5280.00. The 52 week high of XKRX:115180 is â‚©6500.00 and 52 week low is â‚©2038.47.
When is next earnings date of Qurient Co Ltd(XKRX:115180)?
The next earnings date of Qurient Co Ltd(XKRX:115180) is .
Does Qurient Co Ltd(XKRX:115180) pay dividends? If so, how much?
Qurient Co Ltd(XKRX:115180) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers